Alpha Cognition (ACOG) Expected to Announce Earnings on Thursday

Alpha Cognition (NASDAQ:ACOG) is anticipated to post its Q1 2026 results after the market closes on Thursday, May 14th. Analysts expect Alpha Cognition to post earnings of ($0.41) per share and revenue of $3.4230 million for the quarter. Individuals may review the information on the company’s upcoming Q1 2026 earning report for the latest details on the call scheduled for Thursday, May 14, 2026 at 4:30 PM ET.

Alpha Cognition (NASDAQ:ACOG) last issued its earnings results on Thursday, March 26th. The company reported ($0.30) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.03). The firm had revenue of $2.60 million during the quarter, compared to analysts’ expectations of $4.41 million. Alpha Cognition had a negative return on equity of 55.71% and a negative net margin of 202.23%. On average, analysts expect Alpha Cognition to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Alpha Cognition Stock Performance

Shares of Alpha Cognition stock opened at $5.49 on Wednesday. The stock has a market capitalization of $119.54 million, a PE ratio of -4.73 and a beta of 2.38. Alpha Cognition has a 52-week low of $4.50 and a 52-week high of $11.54. The company has a 50-day simple moving average of $6.06 and a two-hundred day simple moving average of $5.94.

Institutional Trading of Alpha Cognition

A number of large investors have recently made changes to their positions in the stock. Ikarian Capital LLC grew its stake in shares of Alpha Cognition by 11.6% in the fourth quarter. Ikarian Capital LLC now owns 1,056,259 shares of the company’s stock worth $6,866,000 after acquiring an additional 110,000 shares during the period. Sphera Funds Management LTD. grew its stake in shares of Alpha Cognition by 67.6% in the fourth quarter. Sphera Funds Management LTD. now owns 567,616 shares of the company’s stock worth $3,690,000 after acquiring an additional 228,864 shares during the period. Opaleye Management Inc. grew its stake in shares of Alpha Cognition by 1,698.5% in the fourth quarter. Opaleye Management Inc. now owns 2,070,784 shares of the company’s stock worth $13,460,000 after acquiring an additional 1,955,642 shares during the period. Cantor Fitzgerald L. P. bought a new stake in shares of Alpha Cognition in the fourth quarter worth approximately $1,062,000. Finally, AWM Investment Company Inc. grew its stake in shares of Alpha Cognition by 52.6% in the fourth quarter. AWM Investment Company Inc. now owns 1,672,168 shares of the company’s stock worth $10,869,000 after acquiring an additional 576,516 shares during the period.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Craig Hallum assumed coverage on shares of Alpha Cognition in a report on Friday, April 17th. They issued a “buy” rating and a $14.00 target price for the company. Wall Street Zen lowered shares of Alpha Cognition from a “hold” rating to a “sell” rating in a research note on Saturday, May 2nd. Finally, HC Wainwright reiterated a “buy” rating and issued a $18.00 price target on shares of Alpha Cognition in a research note on Monday, April 27th. Two analysts have rated the stock with a Buy rating, According to MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $16.00.

Alpha Cognition Company Profile

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.